T&R Biofab Co. Ltd (KQ:246710) — Stock Price
T&R Biofab Co. Ltd (KQ:246710) is currently trading at ₩2585.00 KRW, up 4.23% today. Over the past 52 weeks, shares have ranged between ₩1194.00 and ₩4535.00. This page tracks T&R Biofab Co. Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 246710 market cap.
T&R Biofab Co. Ltd (246710) Stock Price Chart — Daily History & Trading Volume
The chart below tracks T&R Biofab Co. Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
T&R Biofab Co. Ltd Income Statement — Revenue, Profit & Earnings by Year
T&R Biofab Co. Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | ₩4.87 Billion | ₩5.20 Billion | ₩5.75 Billion | ₩3.23 Billion | ₩6.81 Billion |
| Cost of Revenue | ₩2.74 Billion | ₩4.12 Billion | ₩4.21 Billion | ₩3.45 Billion | ₩4.15 Billion |
| Gross Profit | ₩2.13 Billion | ₩1.08 Billion | ₩1.54 Billion | ₩-212.49 Million | ₩2.66 Billion |
| Research & Development | ₩5.51 Billion | ₩4.40 Billion | ₩3.47 Billion | ₩2.82 Billion | ₩3.33 Billion |
| SG&A | ₩8.22 Billion | ₩7.82 Billion | ₩9.23 Billion | ₩5.44 Billion | ₩4.27 Billion |
| Total Operating Expenses | ₩18.17 Billion | ₩17.85 Billion | ₩15.37 Billion | ₩12.00 Billion | ₩12.52 Billion |
| Operating Income | ₩-8.77 Billion | ₩-13.54 Billion | ₩-8.04 Billion | ₩-10.43 Billion | ₩-5.51 Billion |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | ₩-12.72 Billion | ₩-10.68 Billion | ₩-5.51 Billion |
| Interest Expense | ₩2.20 Million | ₩3.24 Million | ₩2.57 Billion | ₩47.33 Million | ₩15.78 Million |
| Income Before Tax | ₩-7.68 Billion | ₩-13.42 Billion | ₩-10.34 Billion | ₩-11.08 Billion | ₩-5.60 Billion |
| Income Tax Expense | — | — | — | — | — |
| Net Income | ₩-7.68 Billion | ₩-13.42 Billion | ₩-10.34 Billion | ₩-11.08 Billion | ₩-5.60 Billion |
T&R Biofab Co. Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes T&R Biofab Co. Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | ₩98.45 Billion | ₩99.82 Billion | ₩75.94 Billion | ₩82.23 Billion | ₩48.51 Billion |
| Total Current Assets | ₩26.29 Billion | ₩57.56 Billion | ₩46.83 Billion | ₩71.31 Billion | ₩42.83 Billion |
| Cash & Equivalents | ₩16.67 Billion | ₩20.23 Billion | ₩35.12 Billion | ₩23.66 Billion | ₩23.28 Billion |
| Short-term Investments | ₩603.74 Million | ₩31.52 Billion | ₩5.30 Billion | ₩34.50 Billion | ₩13.60 Billion |
| Net Receivables | ₩2.20 Billion | ₩1.45 Billion | ₩1.15 Billion | ₩913.12 Million | ₩563.54 Million |
| Inventory | ₩4.72 Billion | ₩2.48 Billion | ₩2.84 Billion | ₩3.48 Billion | ₩3.58 Billion |
| Property, Plant & Equipment | ₩61.33 Billion | ₩34.84 Billion | ₩20.29 Billion | ₩11.00 Billion | ₩2.62 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ₩74.24 Billion | ₩68.62 Billion | ₩36.67 Billion | ₩40.54 Billion | ₩2.45 Billion |
| Total Current Liabilities | ₩40.85 Billion | ₩50.95 Billion | ₩29.10 Billion | ₩1.67 Billion | ₩1.21 Billion |
| Long-term Debt | ₩22.49 Billion | ₩16.20 Billion | ₩6.20 Billion | ₩29.16 Billion | — |
| Net Debt | ₩26.43 Billion | ₩24.27 Billion | — | ₩5.50 Billion | — |
| Total Stockholder Equity | ₩24.21 Billion | ₩31.20 Billion | ₩39.26 Billion | ₩41.69 Billion | ₩46.05 Billion |
| Retained Earnings | ₩-138.33 Billion | ₩-130.52 Billion | ₩-116.85 Billion | ₩-106.70 Billion | ₩-25.66 Billion |
T&R Biofab Co. Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how T&R Biofab Co. Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩-11.73 Billion | ₩-6.96 Billion | ₩-5.89 Billion | ₩-7.56 Billion | ₩-8.38 Billion |
| Capital Expenditures | ₩2.81 Billion | ₩12.73 Billion | ₩10.83 Billion | ₩1.13 Billion | ₩1.69 Billion |
| Free Cash Flow | ₩-14.54 Billion | ₩-19.69 Billion | ₩-16.92 Billion | ₩-16.60 Billion | ₩-10.54 Billion |
| Investing Cash Flow | ₩11.69 Billion | ₩-37.52 Billion | ₩17.58 Billion | ₩-33.78 Billion | ₩1.03 Billion |
| Financing Cash Flow | ₩-3.51 Billion | ₩29.58 Billion | ₩-219.47 Million | ₩41.66 Billion | ₩26.03 Billion |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | ₩792.02 Million | ₩1.35 Billion | ₩3.62 Billion | ₩722.11 Million | ₩435.02 Million |
| Depreciation | ₩2.25 Billion | ₩2.02 Billion | ₩1.95 Billion | ₩1.74 Billion | ₩1.27 Billion |
| Change in Cash | ₩-3.56 Billion | ₩-14.89 Billion | ₩11.46 Billion | ₩385.94 Million | ₩18.56 Billion |
T&R Biofab Co. Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track T&R Biofab Co. Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | -220.96 | — | — |
| Jun 30, 2025 | -131.80 | — | — |
| Mar 31, 2025 | -165.70 | — | — |
| Dec 31, 2024 | 177.90 | — | — |
| Sep 30, 2024 | -146.42 | — | — |
| Jun 30, 2024 | -29.37 | — | — |
| Mar 31, 2024 | -238.29 | — | — |
| Dec 31, 2023 | -8.38 | — | — |